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The studies in the present thesis focused on expanding the donor liver pool 
through the use of machine perfusion of extended criteria donor (ECD) livers, 
with a particular focus on the biliary tree. 
In chapter 1, the thesis and outline of the various chapters were introduced. In 
chapter 2, ways to expand the donor liver pool were addressed.1 One of the 
most impactful ways to increase the number of available donor livers for 
transplantation is by transplanting ECD livers. Compared to optimal standard 
criteria donor livers, ECD grafts are inherently of lesser quality and have endured 
more injury, and transplantation of these organs carries a higher risk of 
complications. The gold standard for preservation of donor livers, using static 
cold storage in which the organs are cooled and transported on ice, causes too 
much additional injury to these already high-risk ECD organs. Therefore, 
management of these grafts requires a different approach. Machine perfusion 
is a novel technique that provides better protection against ischemic injury and 
allows for the resuscitation and careful selection of donor livers. Depending on 
the indication for machine perfusion, it can be implemented during different 
phases of transplantation (procurement, transportation and upon arrival at the 
transplanting center), at a range of temperatures and using various preservation 
solutions. As machine perfusion continues to gain clinical application in the 
coming years, it is likely that a tailored approach will be implemented depending 
on various indications. 
Chapter 3 describes the technique of normothermic machine perfusion (NMP) 
in a video article.2 At 37°C, oxygenated NMP renders the organ metabolically 
active and allows for viability assessment. In order to create a physiological 
environment, NMP was performed using a perfusion solution based on packed 
red bloods cells (RBC), fresh frozen plasma (FFP) and a mix of nutrients, trace 
elements and antibiotics. An online video explains how NMP is performed using 
the Liver Assist (Organ Assist) perfusion device, which provides pressure-
controlled continuous flow through the portal vein and pulsatile flow through 
the hepatic artery. In contrast to other perfusion devices, such as Metra 
(OrganOx), this device was not designed to be used during transportation and 
does not offer automated monitoring and adjustments of biochemistry in 
perfusate. The Liver Assist can therefore only be used at the procurement or 
implantation center. However, it is much cheaper, offers equal perfusion quality 
and most importantly, allows for machine perfusion at a range of temperatures. 
As human blood products are scarce and their use is logistically complex, we 
sought to develop an NMP perfusion solution that circumvents the use of human 
blood products. In chapter 4, RBCs were first replaced by an acellular bovine 
hemoglobin (HBOC-201) and this modified perfusion solution was tested in six 
discarded donor livers. Subsequently FFPs were replaced by gelofusine and a 
mix of other additives and the resulting solution was tested using another six 
donor livers.3 Both groups were compared to the historical cohort of twelve 
donor livers in which NMP was performed using a perfusion solution based on 
RBCs and FFPs. The livers in the HBOC-201 perfused groups displayed 
significantly better function, including higher cumulative bile production, portal 
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and arterial flows, and hepatic adenosine triphosphate (ATP) content. This was 
likely due to the HBOC-201 molecule’s lower affinity for oxygen compared to 
human hemoglobin and smaller size, causing it to release oxygen more readily 
and allowing it to penetrate more deeply into the tissue. Disadvantages of using 
HBOC-201, however, include the potential formation of methemoglobin and the 
inability to remove HBOC-201 from samples, potentially leading to interference 
of spectrophotometric analyses of the perfusion fluid. Lastly, HBOC-201 and 
gelofusine are bovine-derived products, and future research should aim to find 
animal-free alternatives. 
Another important property of HBOC-201 is that it, in contrast to RBCs, can be 
used as an oxygen carrier at lower temperatures. This allows for a perfusion 
protocol involving a period of dual hypothermic oxygenated machine perfusion 
(DHOPE), followed by controlled oxygenated rewarming (COR) and finally NMP. 
Chapter 5 showed that sequential DHOPE-COR-NMP using an HBOC-based 
perfusion fluid offers a novel method of liver machine perfusion for combined 
resuscitation and viability testing of suboptimal livers prior to transplantation. 
In this case series, seven livers that were initially declined for transplantation 
were perfused using DHOPE-COR-NMP, of which five were successfully 
transplanted after meeting all hepato-biliary viability criteria during NMP. The 
primary endpoint, graft survival at 3 months, was 100%. Furthermore, post-
operative peak ALT was lower in our recipients than in the studies that 
compared SCS to NMP only,4,5 which may have been attributable to the DHOPE-
induced amelioration of ischemia-reperfusion injury.6-8 In addition, none of the 
recipients showed clinical signs of non-anastomotic biliary strictures (NAS), 
although as this was not the primary outcome we did not perform routine 
imaging and subclinical cases may have been missed. In conclusion, this study 
showed that sequential perfusion with DHOPE-COR-NMP using HBOC-201 is 
feasible and safe. Despite the promising results, larger cohorts with longer 
follow-up are required in order to draw any conclusions regarding the protocol’s 
efficacy in safely increasing the number of donor livers for transplantation and 
reducing complications. 
In chapter 6, we showed that biliary bicarbonate, pH, LDH, glucose and the 
bile/perfusate glucose ratio are accurate predictors of histological biliary injury 
during NMP. Histological bile duct injury was assessed using a clinically relevant 
scoring system and livers were divided into a group with high and low injury. 
Biliary biochemistry markers were subsequently analyzed for their predictive 
value using AUC-ROC curves. Establishing biliary viability biomarkers is very 
important, as up until then NMP viability assessment was mainly based on 
hepatocellular criteria, despite the fact that biliary injury prior to transplantation 
has been directly linked with the development of NAS. Especially biliary 
bicarbonate, rather than biliary pH as had been suggested by other groups5, was 
able to predict biliary viability during NMP. Low biliary pH and bicarbonate do 
not only reflect biliary injury/dysfunction, but may also contribute to additional 
biliary injury due to an absent bicarbonate umbrella, which helps protect against 
the cytotoxic bile salts.9 Since the publication of this paper, we have also found 
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that the delta between bile and perfusate pH and bicarbonate is even more 
discriminatory than their absolute values in bile. Biliary glucose is dependent on 
perfusate or blood glucose, and most post-ischemic livers have increased 
glucose levels due to glycogenolysis.10 For this reason, it is important to 
determine the ratio between bile and perfusate glucose. One issue with the use 
of biliary biochemistry in assessing biliary viability is that some livers produce 
very little or no recorded bile during NMP. Donor livers that did not produce bile 
during NMP have, however, also been successfully transplanted and we 
therefore advise that especially livers with an increased risk for post-transplant 
cholangiopathy be assessed for biliary viability.5,11 
In chapter 7, we showed that early release of hepatocyte- and cholangiocyte-
derived micro-RNAs (HDmiR-122 and CDmiR-222, respectively) in perfusate and 
bile can predict late hepato-cholangiocellular injury and function of donor livers 
during NMP. These analyses were performed in a group of twelve donor livers 
that were declined for transplantation. Overall, levels of both miRs in perfusate 
and bile were lower in livers with low hepato-cholangiocellular injury and good 
hepato-cholangiocellular function. Levels of HDmiR-122 in perfusate correlated 
more strongly with hepato-cholangiocellular parameters compared to levels in 
bile, while levels of CDmiR-222 in bile correlated more strongly with parameters 
compared to levels in perfusate, confirming their cell-specific origin. The HDmiR-
122/CDmiR-222 ratio was significantly higher in perfusate of low-quality livers 
compared to the ratio in high-quality livers. These miRs are differentially 
released into perfusate and bile and may in the future be used as biomarkers for 
assessment of graft viability during machine perfusion. 
Chapter 8 compared the ability of various preservation solutions in protecting 
against histological bile duct injury, which has been shown to be predictive of 
the development of NAS after transplantation.12 In this study, extrahepatic bile 
duct segments from discarded donor livers were cold stored in five different 
preservation solutions after a period of SCS in University of Wisconsin (UW) 
solution and subsequently assessed for histological bile duct injury on HE 
sections. Histidine-tryptophan-ketoglutarate (HTK) solution led to higher bile 
duct injury compared to UW solution. This carries important clinical implications 
as HTK solution is widely used and donor livers with a high-risk of post-transplant 
cholangiopathy are increasingly being transplanted. However, the benefits of 
HTK solution that have been described in the literature, including its low 
viscosity and fast temperature reduction13, may have been masked in the 
current study design as the bile duct segments were small and a solution switch 
from UW to HTK solution may have caused additional injury, too. Furthermore, 
the addition of poly-ethylene glycols (PEGs) to HTK and UW solution resulted in 
a slight but non-significant, reduction in bile duct injury. PEGs are FDA-approved 
non-toxic water-soluble compounds that are widely used, including clinically, 
with high flexibility, hydrophilicity and protein-rejecting properties.14 Previous 
research has shown that PEGs may play an important role in the preservation of 
liver and intestine, which closely resembles bile ducts.15-20 Therefore the 
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addition of PEGs to preservation solutions may be a readily implementable and 
affordable method to protect the biliary tree that warrants further investigation. 
In the final study reported in chapter 9, we established a novel method called 
precision-cut bile duct slices (PCBDS) to study human bile ducts, circumventing 
the use of laboratory animals. Using this ex vivo model, human extrahepatic bile 
ducts derived from discarded donor livers were cut into small slices and 
incubated for up to six days. This technique maintained intact anatomical 
organization of cell structures and allowed for the study of spatiotemporal 
differentiation and migration of peribiliary gland (PBG) cells. PBG are niches 
containing progenitor and stem cells embedded in the bile duct wall, which play 
a crucial role in the development of NAS after transplantation.21,22 We showed 
that after severe bile duct injury, PBG cells were able to respond with 
proliferation, migration and maturation to restore biliary epithelium. This was 
the first study to provide evidence that PBG respond to biliary injury by 
restoration of biliary epithelium and confirms the protective role of PBG in the 
development of large duct cholangiopathies. A limitation of this study was that 
intra- and extrahepatic bile ducts could not be studied separately, as there is a 
limit to the number of PCBDS that can be obtained per liver. 
 
  
139776_Alix Matton_BNW.indd   175 13-11-19   13:21





The studies described in the present thesis have contributed to the body of 
knowledge regarding the value of machine perfusion in liver transplantation. 
Machine perfusion in liver transplantation, and especially its role in protecting 
the bile ducts, holds great potential in expanding and improving the field of liver 
transplantation. Clearly, many questions remain unanswered and new 
challenges remain to be addressed, as will subsequently be discussed.  
In the current thesis, we have shown that NMP can be used to expand the donor 
liver pool by identifying viable donor livers amongst livers initially declined for 
transplantation. NMP, which renders the organ metabolically active, could 
potentially also be used to make livers transplantable through the 
administration of drugs ex situ, if necessary also using higher dosages than 
would be possible in vivo. One area which has the potential to increase the 
donor pool substantially would be through the defatting of livers prior to 
transplantation, as currently around 40% of livers are declined for 
transplantation due to (expected) steatosis in the UK and Spain.23,24 
Furthermore, the regenerative capacity of the biliary tree could potentially be 
restored during machine perfusion by implanting or infusing PBG stem cells into 
injured bile ducts. Stem cells could even be obtained from a cholecystectomy of 
the recipient, expanded in culture and implanted into the donor liver during 
machine perfusion, thereby possibly also reducing the immunogenic influence 
in the development of NAS. MiRs should be further investigated for their use as 
biomarkers for hepato-cholangiocellular injury and function during machine 
perfusion. As miR assays are becoming more rapid to execute, these cell-specific 
miRs hold the potential to track processes in real time during machine perfusion. 
These miRs could potentially also provide useful real-time information about 
organ quality during organ procurement, storage, perfusion, transplantation 
and post-transplantation. Lastly, a perfusion fluid based on HBOC-201 is very 
promising as it can be used at various temperatures and allows for superior 
oxygenation, as the hemoglobin molecule releases its oxygen more easily and 
penetrates more deeply into the tissue. However, a bovine-derived solution 
could theoretically still lead to the transmission of infectious and immunogenic 
agents. Furthermore, for ethical reasons animal-free alternatives should be 
developed. For these reasons, synthetic oxygen carriers should be investigated 
as alternative oxygen carriers for machine perfusion. 
As the application of machine perfusion of donor livers is growing and different 
variants of it are increasingly being applied around the world, it might be very 
worthwhile to compile all the information regarding donor characteristics, 
machine perfusion and transplantation information together in order to create 
an extensive body of knowledge regarding machine perfusion. Such a database 
could be used to identify the most optimal combinations between liver type and 
type of machine perfusion. The optimal machine perfusion temperature, 
solution, pressure, phase (i.e. pre-ischemic, during transportation or end-
ischemic), duration and technique (e.g. dual versus single) could then be 
compared using large cohorts, as a frequently encountered issue with machine 
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perfusion studies is the relatively small sample sizes that are used due to the 
scarcity of human donor livers and high costs. Trials should subsequently be 
carried out to test the optimal application of machine perfusion for various 
indications, as well as to evaluate its cost-effectiveness. 
Machine perfusion is likely going to, one day, replace static cold storage 
altogether. Until that time, however, it is of utmost importance that donor livers 
are preserved in an optimal preservation solution. Attention should be focused, 
in particular, on eliminating additional biliary injury instead of only on liver 
injury, as has been the main focus in literature. The addition of PEGs to 
preservation solutions is promising, readily implementable and relatively cheap 
and future studies should be focused on their use in liver preservation. The 
histological morphology of the bile ducts could be further investigated using 
electron microscopy. This was attempted for the study in chapter 8, but the bile 
ducts were too severely injured to be able to draw any conclusions and future 
studies should focus on preserving the bile ducts immediately after 
procurement of the liver. An experimental study that could be performed is to 
preserve human bile duct segments in various preservation solutions, as was 
done in chapter 8, and subsequently applying the PCBDS method to compare 
the proliferative capacity of the PBG cells in vitro after preservation in various 
solutions. Furthermore, the PCBDS model could also be used to stimulate PBG 
proliferation with the addition of various components. Bile acids, such as 
taurocholic acid, and Wnt signaling factors, which play a role in intestinal stem 
cell proliferation, could be used to stimulate PBG proliferation.25,26 These factors 
could then be added to the biliary tree during machine perfusion to reduce or 
prevent the development of NAS after transplantation. 
Machine perfusion will possibly lead to the establishment of organ banks where 
livers are stored for extended periods of time. This would allow for the elective 
transplantation of livers in the most optimal setting, with the recipient in 
optimal condition and international matching without time restrictions. 
Machine perfusion has the potential to allow for the resuscitation (defatting, 
chemotherapy etc.) and perhaps even complete de- and recellulization of 
organs, as is currently being investigated at Massachusetts General Hospital in 
Boston by Dr. K. Uygun and Dr. B. Uygun.27 Subsequently, it is likely that 
optimized livers will be preserved using subzero non-freezing techniques, 
allowing for the long-term storage of transplant organs.28 
In summary, the studies reported in the present thesis have contributed to the 
application of machine perfusion of human donor livers and include one of the 
first clinical applications of NMP that led to literal expansion of the donor liver 
pool. Moreover, this thesis has contributed to the establishment and 
identification of suitable biomarkers during machine perfusion, with a particular 
focus on protecting the biliary tree and thereby hopefully reducing the risk of 
NAS. Machine perfusion is an exciting and booming field that is in the starting 
blocks of revolutionizing organ transplantation, holding great potential to 
substantially increase both the quantity and quality of lives of transplant 
patients.  
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